Mr. Klain named Pfizer as one of the companies the team would meet with but didn’t specify the others. The other drugmakers furthest along in COVID-19 vaccine development include Moderna, AstraZeneca and Johnson & Johnson.
“We’re going to have meetings between our top scientific advisers and the officials of these drug companies,” Mr. Klain told CNBC.
He stressed the importance of planning for vaccine distribution, saying: “It’s great to have a vaccine, but vaccines don’t save lives. Vaccinations save lives. And that means you’ve got to get that vaccine into people’s arms all over this country. It’s a giant logistical project.”
Read the full article here.
More articles on pharmacy:
HHS partners with 19 pharmacy networks for COVID-19 vaccine allocation
COVID-19 vaccines likely to have mild but painful side effects, scientists say
AstraZeneca says its cancer drug didn’t help COVID-19 patients in clinical trials
